Register entry
Octapharma USA Inc
- Registered sites
- 0
- Drug products
- 24
- Live patents
- 0
- Countries
- 0
- Base
- Unknown
Sites
Facilities
0No registered facilities
This company holds drug listings or approvals but operates no registered establishment of its own, which is normal for an NDA holder that outsources manufacturing.
Catalogue
Marketed products
24Showing 24 of 24.
| Brand | Generic name | Form | Category |
|---|---|---|---|
| Albumin (Human) | Albumin Human | SOLUTION | BLA |
| Albumin (Human) | Albumin Human | SOLUTION | BLA |
| Albumin (Human) | Albumin Human | SOLUTION | BLA |
| Balfaxar | Prothrombin Complex Concentrate (Human) | POWDER, FOR SOLUTION | BLA |
| Cutaquig | immunoglobulin G | SOLUTION | BLA |
| Fibryga | Fibrinogen (Human) | KIT | BLA |
| Fibryga | Fibrinogen (Human) | POWDER, FOR SOLUTION | BLA |
| Fibryga | Fibrinogen (Human) | POWDER, FOR SOLUTION | BLA |
| NUWIQ | Antihemophilic Factor (Recombinant) | KIT | BLA |
| NUWIQ | Antihemophilic Factor (Recombinant) | KIT | BLA |
| NUWIQ | Antihemophilic Factor (Recombinant) | KIT | BLA |
| NUWIQ | Antihemophilic Factor (Recombinant) | KIT | BLA |
| NUWIQ | Antihemophilic Factor (Recombinant) | KIT | BLA |
| NUWIQ | Antihemophilic Factor (Recombinant) | KIT | BLA |
| NUWIQ | Antihemophilic Factor (Recombinant) | KIT | BLA |
| NUWIQ | Antihemophilic Factor (Recombinant) | KIT | BLA |
| Octagam Immune Globulin (Human) | Immune Globulin | SOLUTION | BLA |
| Octagam Immune Globulin (Human) | Immune Globulin | SOLUTION | BLA |
| Octaplas | human plasma proteins | SOLUTION | BLA |
| Octaplas | human plasma proteins | SOLUTION | BLA |
| Octaplas | human plasma proteins | SOLUTION | BLA |
| Octaplas | human plasma proteins | SOLUTION | BLA |
| Panzyga | immune globulin intravenous (human) | SOLUTION | BLA |
| Wilate - von Willebrand Factor/Coagulation Factor VIII Complex (Human) | von Willebrand Factor/Coagulation Factor VIII Complex (Human) | POWDER, FOR SOLUTION | BLA |
Provenance
Facility and operations data from the FDA Drug Establishments Current Registration Site. Product data from the openFDA National Drug Code Directory. Patent and exclusivity data from the FDA Orange Book. Shortage data from the FDA drug shortage database. Contact details the FDA publishes for registered establishments are deliberately not reproduced here. This entry is compiled from public records and has not been claimed by the company.